Impact of Time-Sensitive Recruitment on Representativeness in The Budesonide in Babies Randomized Controlled Trial
Saturday, April 25, 2026
3:30pm - 5:45pm ET
Mar Romero-Lopez, UT Health. Houston, Houston, TX, United States; shampa Saha, RTI International, Durham, NC, United States; Namasivayam Ambalavanan, University of Alabama School of Medicine, Birmingham, AL, United States; Anup Katheria, University of California, San Diego School of Medicine, San Diego, CA, United States; Jon E. Tyson, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, United States; Ravi M. Patel, Children's Healthcare of Atlanta and Emory University, Atlanta, GA, United States; Elliott Weiss, University of Washington School of Medicine, Seattle, WA, United States; Susan Wootton, McGovern Medical School at the University of Texas Health Science Center at Houston, Bellaire, TX, United States; Kanekal Gautham, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, United States; Gabriela Dominguez, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, United States; Rebecca A.. Dorner, Sharp Mary Birch Hospital for Women & Newborns, San Diego, CA, United States; Matthew Rysavy, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, United States; on behalf of NICHD Neonatal Research Network, NICHD Neonatal Research Network, Bethesda, MD, United States